MENU
+Compare
LTRN
Stock ticker: NASDAQ
AS OF
Dec 26 closing price
Price
$3.48
Change
+$0.14 (+4.19%)
Capitalization
38.92M

LTRN Lantern Pharma Forecast, Technical & Fundamental Analysis

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development... Show more

LTRN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for LTRN with price predictions
Dec 26, 2025

LTRN's RSI Indicator recovers from oversold territory

The RSI Oscillator for LTRN moved out of oversold territory on November 24, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In of the 28 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 73 cases where LTRN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where LTRN advanced for three days, in of 240 cases, the price rose further within the following month. The odds of a continued upward trend are .

LTRN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 10, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LTRN as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LTRN turned negative on December 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 56 similar instances when the indicator turned negative. In of the 56 cases the stock turned lower in the days that followed. This puts the odds of success at .

LTRN moved below its 50-day moving average on December 10, 2025 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for LTRN moved below the 200-day moving average on December 16, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LTRN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LTRN entered a downward trend on December 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.060) is normal, around the industry mean (26.614). P/E Ratio (0.000) is within average values for comparable stocks, (51.532). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (310.546).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LTRN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LTRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
LTRN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

LTRN is expected to report earnings to rise 38.46% to -54 cents per share on March 05

Lantern Pharma LTRN Stock Earnings Reports
Q4'25
Est.
$-0.54
Q3'25
Beat
by $0.05
Q2'25
Beat
by $0.13
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.14
The last earnings report on November 13 showed earnings per share of -38 cents, beating the estimate of -43 cents. With 49.72K shares outstanding, the current market capitalization sits at 38.92M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1920 McKinney Avenue
Phone
+1 972 277-1136
Employees
21
Web
https://www.lanternpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DTST5.070.04
+0.80%
Data Storage Corp
CAT583.00-0.76
-0.13%
Caterpillar
HOPE11.25-0.03
-0.27%
Hope Bancorp
URBN77.05-1.14
-1.46%
Urban Outfitters
NMRA1.78-0.03
-1.66%
Neumora Therapeutics

LTRN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with AXON. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
+4.19%
AXON - LTRN
36%
Loosely correlated
-1.24%
SYRE - LTRN
33%
Poorly correlated
-0.33%
RLAY - LTRN
32%
Poorly correlated
-1.04%
RGNX - LTRN
32%
Poorly correlated
-2.07%
CUE - LTRN
32%
Poorly correlated
+34.77%
More